G1 Therapeutics, Inc.

NasdaqGS:GTHX 株式レポート

時価総額:US$116.1m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

G1 Therapeutics 将来の成長

Future 基準チェック /46

G1 Therapeutics利益と収益がそれぞれ年間48.3%と21.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に1.3% 47.3%なると予測されています。

主要情報

49.5%

収益成長率

48.8%

EPS成長率

Biotechs 収益成長24.4%
収益成長率19.8%
将来の株主資本利益率1.3%
アナリストカバレッジ

Low

最終更新日25 Jun 2024

今後の成長に関する最新情報

G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 04
G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

G1 Therapeutics: Failure Of Breast Cancer Underscores Long-Term Uncertainty

Jun 24

Shareholders May Not Be So Generous With G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Compensation And Here's Why

Jun 07
Shareholders May Not Be So Generous With G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Compensation And Here's Why

Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

May 28
Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 04
G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Why G1 Therapeutics Is A Speculative 'Buy' In The Oncology Biotech Landscape

Mar 22

Why Investors Shouldn't Be Surprised By G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 44% Share Price Plunge

Feb 27
Why Investors Shouldn't Be Surprised By G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 44% Share Price Plunge

Does G1 Therapeutics (NASDAQ:GTHX) Have A Healthy Balance Sheet?

Feb 06
Does G1 Therapeutics (NASDAQ:GTHX) Have A Healthy Balance Sheet?

G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock Catapults 61% Though Its Price And Business Still Lag The Industry

Jan 04
G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock Catapults 61% Though Its Price And Business Still Lag The Industry

Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

Jun 08
Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

New Forecasts: Here's What Analysts Think The Future Holds For G1 Therapeutics, Inc. (NASDAQ:GTHX)

May 08
New Forecasts: Here's What Analysts Think The Future Holds For G1 Therapeutics, Inc. (NASDAQ:GTHX)

The G1 Therapeutics, Inc. (NASDAQ:GTHX) Analysts Have Been Trimming Their Sales Forecasts

Nov 04
The G1 Therapeutics, Inc. (NASDAQ:GTHX) Analysts Have Been Trimming Their Sales Forecasts

G1 Therapeutics: Catalysts Stacking

Oct 20

G1 Therapeutics: Building A Franchise

Sep 29

Analysts Just Published A Bright New Outlook For G1 Therapeutics, Inc.'s (NASDAQ:GTHX)

Aug 04
Analysts Just Published A Bright New Outlook For G1 Therapeutics, Inc.'s (NASDAQ:GTHX)

G1 Therapeutics Q2 2022 Earnings Preview

Aug 02

G1 Therapeutics: Take Advantage Of The November Data

Jul 22

G1 Therapeutics granted regulatory nod for cancer therapy in China

Jul 13

G1 Therapeutics: Needs To Expand Labels And Commercialize Better

Apr 27

Health Check: How Prudently Does G1 Therapeutics (NASDAQ:GTHX) Use Debt?

Apr 19
Health Check: How Prudently Does G1 Therapeutics (NASDAQ:GTHX) Use Debt?

G1 Therapeutics: Biotech With FDA Approved Drug Plus Additional Potential

Feb 08

業績と収益の成長予測

NasdaqGS:GTHX - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20263271859653345
12/31/202592-132405
12/31/202471-287-125
3/31/202484-31-18-18N/A
12/31/202383-48-38-38N/A
9/30/202378-71-56-56N/A
6/30/202389-78-67-67N/A
3/31/202357-126-120-119N/A
12/31/202251-148-129-129N/A
9/30/202247-154-133-133N/A
6/30/202228-171-146-145N/A
3/31/202224-171-143-143N/A
12/31/202131-148-132-132N/A
9/30/202142-134-129-129N/A
6/30/202164-103-91-91N/A
3/31/202160-95-84-84N/A
12/31/202045-99-84-84N/A
9/30/202029-109-83-82N/A
6/30/20202-130-113-111N/A
3/31/2020N/A-130-108-105N/A
12/31/2019N/A-122-102-100N/A
9/30/2019N/A-111-93-91N/A
6/30/2019N/A-99-83-82N/A
3/31/2019N/A-89-79-78N/A
12/31/2018N/A-85-75-74N/A
9/30/2018N/A-78-68-68N/A
6/30/2018N/A-74-65-65N/A
3/31/2018N/A-68-60-59N/A
12/31/2017N/A-65N/A-51N/A
9/30/2017N/A-60N/A-45N/A
6/30/2017N/A-52N/A-37N/A
3/31/2017N/A-45N/A-29N/A
12/31/2016N/A-35N/A-25N/A
12/31/20151-22N/A-14N/A
12/31/20141-7N/A-6N/A

アナリストによる今後の成長予測

収入対貯蓄率: GTHXは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 2.4% ) よりも高い成長率であると考えられます。

収益対市場: GTHX今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: GTHX今後 3 年以内に収益を上げることが予想されます。

収益対市場: GTHXの収益 ( 21.3% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: GTHXの収益 ( 20% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: GTHXの 自己資本利益率 は、3年後には低くなると予測されています ( 1.3 %)。


成長企業の発掘